skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia BEIJERINCK study design and baseline characteristics
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia BEIJERINCK study design and baseline characteristics
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia BEIJERINCK study design and baseline characteristics

Franck Boccara Princy Kumar; Bruno Caramelli; Alexandra Calmy; J. Antonio G Lopez; Sarah Bray; Marcoli Cyrille; Robert S Rosenson

American heart journal v. 220, p. 203-212, 2020

New York 2020

Acesso online. A biblioteca também possui exemplares impressos.

2
Long-term effects of evolocumab in participants with HIV and dyslipidemia results from the open-label extension period
Long-term effects of evolocumab in participants with HIV and dyslipidemia results from the open-label extension period
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term effects of evolocumab in participants with HIV and dyslipidemia results from the open-label extension period

Franck Boccara Bruno Caramelli; Alexandra Calmy; Princy Kumar; J. Antonio G Lopez; Sarah Bray; Marcoli Cyrille; Robert S Rosenson

Aids v. 36, n. 5, p. 675-682, 2022

Philadelphia 2022

Acesso online. A biblioteca também possui exemplares impressos.

3
Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK Study
Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK Study

Franck Boccara Princy N Kumar; Bruno Caramelli; Alexandra Calmy; J. Antonio G Lopez; Sarah Bray; Marcoli Cyrille; Robert S Rosenson

Journal of the american college of cardiology v. 75, n. 20, p. 2570-2584, 2020

New York 2020

Acesso online. A biblioteca também possui exemplares impressos.

4
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1

Emu, Brinda ; Fessel, Jeffrey ; Schrader, Shannon ; Kumar, Princy ; Richmond, Gary ; Win, Sandra ; Weinheimer, Steven ; Marsolais, Christian ; Lewis, Stanley

The New England journal of medicine, 2018-08, Vol.379 (7), p.645-654 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

Gerding, Dale N ; Kelly, Ciaran P ; Rahav, Galia ; Lee, Christine ; Dubberke, Erik R ; Kumar, Princy N ; Yacyshyn, Bruce ; Kao, Dina ; Eves, Karen ; Ellison, Misoo C ; Hanson, Mary E ; Guris, Dalya ; Dorr, Mary Beth

Clinical infectious diseases, 2018-08, Vol.67 (5), p.649-656 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
6
Weight gain following switch to integrase inhibitors from non-nucleoside reverse transcriptase or protease inhibitors in people living with HIV in the United States: analyses of electronic medical records and prescription claims
Weight gain following switch to integrase inhibitors from non-nucleoside reverse transcriptase or protease inhibitors in people living with HIV in the United States: analyses of electronic medical records and prescription claims
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weight gain following switch to integrase inhibitors from non-nucleoside reverse transcriptase or protease inhibitors in people living with HIV in the United States: analyses of electronic medical records and prescription claims

Tse, Jenny ; Prajapati, Girish ; Zhao, Xiaohui ; Near, Aimee M ; Kumar, Princy N

Current medical research and opinion, 2023-09, Vol.39 (9), p.1-1246 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
7
Weight gain after antiretroviral therapy initiation in people living with HIV in the United States: analyses of electronic medical records and prescription claims
Weight gain after antiretroviral therapy initiation in people living with HIV in the United States: analyses of electronic medical records and prescription claims
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weight gain after antiretroviral therapy initiation in people living with HIV in the United States: analyses of electronic medical records and prescription claims

Zhao, Xiaohui ; Prajapati, Girish ; Tse, Jenny ; Near, Aimee M. ; Kumar, Princy N.

Current medical research and opinion, 2023-07, Vol.39 (7), p.997-1006 [Periódico revisado por pares]

England: Taylor & Francis

Texto completo disponível

Citações Citado por
8
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

Eron, Joseph J, Prof ; Young, Benjamin, MD ; Cooper, David A, Prof ; Youle, Michael, MD ; DeJesus, Edwin, MD ; Andrade-Villanueva, Jaime, MD ; Workman, Cassy, MD ; Zajdenverg, Roberto, MD ; Fätkenheuer, Gerd, Prof ; Berger, Daniel S, MD ; Kumar, Princy N, MD ; Rodgers, Anthony J, MS ; Shaughnessy, Melissa A, MS ; Walker, Monica L, BS ; Barnard, Richard JO, PhD ; Miller, Michael D, PhD ; DiNubile, Mark J, MD ; Nguyen, Bach-Yen, MD ; Leavitt, Randi, MD ; Xu, Xia, PhD ; Sklar, Peter, Dr

The Lancet (British edition), 2010-01, Vol.375 (9712), p.396-407 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

Eron, Joseph J, Prof ; Cooper, David A, Prof ; Steigbigel, Roy T, Prof ; Clotet, Bonaventura, MD ; Gatell, Jose M, Prof ; Kumar, Princy N, Prof ; Rockstroh, Jurgen K, Prof ; Schechter, Mauro, Prof ; Markowitz, Martin, Prof ; Yeni, Patrick, MD ; Loutfy, Mona R, MD ; Lazzarin, Adriano, Prof ; Lennox, Jeffrey L, Prof ; Strohmaier, Kim M, BS ; Wan, Hong, MS ; Barnard, Richard JO, PhD ; Nguyen, Bach-Yen T, MD ; Teppler, Hedy, MD

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
A Multicenter Randomized Controlled Trial of Intensive Group Therapy for Tobacco Treatment in HIV-Infected Cigarette Smokers
A Multicenter Randomized Controlled Trial of Intensive Group Therapy for Tobacco Treatment in HIV-Infected Cigarette Smokers
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Multicenter Randomized Controlled Trial of Intensive Group Therapy for Tobacco Treatment in HIV-Infected Cigarette Smokers

Stanton, Cassandra A ; Kumar, Princy N ; Moadel, Alyson B ; Cunningham, Chinazo O ; Schechter, Clyde B ; Kim, Ryung S ; Shuter, Jonathan

Journal of acquired immune deficiency syndromes (1999), 2020-04, Vol.83 (4), p.405-414 [Periódico revisado por pares]

United States: Copyright Wolters Kluwer Health, Inc. All rights reserved

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (301)
  2. Anais de Congresso  (2)
  3. Web Resources  (1)
  4. Livros  (1)
  5. Book Chapters  (1)
  6. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1999  (9)
  2. 1999Até2004  (15)
  3. 2005Até2010  (20)
  4. 2011Até2016  (55)
  5. Após 2016  (208)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Boccara, F
  2. Rosenson, R
  3. Kumar, P
  4. Calmy, A
  5. Bray, S

Neste Assunto:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Male
  5. Female

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.